Characterization of a PERK Kinase Inhibitor with Anti-Myeloma Activity

SIMPLE SUMMARY: Multiple myeloma is a bone marrow cancer that represents a severe health threat. The drugs used nowadays in chemotherapy often encounter resistance leading to a dramatic loss of their efficacy, which consequently affects patients’ survival. Previous studies have shown that the protei...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Cancers (Basel)
Prif Awduron: Bagratuni, Tina, Patseas, Dimitrios, Mavrianou-Koutsoukou, Nefeli, Liacos, Christine Ivy, Sklirou, Aimilia D., Rousakis, Pantelis, Gavriatopoulou, Maria, Terpos, Evangelos, Tsitsilonis, Ourania E., Trougakos, Ioannis P., Kastritis, Efstathios, Dimopoulos, Meletios A.
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: MDPI 2020
Pynciau:
Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC7601861/
https://ncbi.nlm.nih.gov/pubmed/33028016
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers12102864
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg